Clinical Trial Update: Viral Kinetic Study With Viramidine in Therapy-Naive Patients With Chronic Hepatitis C [Phase 2]

View source ↗

Summary

A Phase 2 viral kinetic study of Viramidine in therapy-naive patients with chronic hepatitis C has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Viramidine (viramidine)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Hepatitis C, Chronic | Phase 2 | Status: TERMINATED